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Efforts to mitigate the devastation of tobacco-attributable 
morbidity and mortality in the European Union (EU) 
consist of its newly adopted Tobacco Products Directive 
(TPD) along with the first-ever health treaty, the WHO 
Framework Convention on Tobacco Control (FCTC). The aim 
of this Horizon 2020 project entitled European Regulatory 
Science on Tobacco: Policy Implementation to Reduce 
Lung Disease (EUREST-PLUS) is to monitor and evaluate 
the impact of the implementation of the TPD across the 
EU, within the context of WHO FCTC ratification. The 
EUREST-PLUS ITC cohort study of adult smokers in six EU 
MS (Germany, Greece, Hungary, Poland, Romania, Spain), 
uses a pre- vs. post-TPD implementation study design, 
evaluating the impact of several tobacco control policy 
provisions, including but not limited to health warning 
labels, smoke free areas and electronic cigarettes.  The 
study is designed to generate strong inferences about 
the effectiveness of tobacco control policies, as well as 
to elucidate the mechanisms and factors by which policy 
implementation translates to population impact. Findings 
from EUREST-PLUS have potential global implications for 
implementation of innovative tobacco control policies and 
its impact on the prevention of lung diseases.
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